ReviewClinical interventions in aging2012
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients.
Andrew J Yee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it